Effects of a novel vesamicol receptor ligand, m-(iodobenzyl)trozamicol, on the canine isolated, blood-perfused atrioventricular node preparation

Japanese Journal of Pharmacology

Volumn 82, Issue 2, 2000, Pages 150-154

  Sugiyama, Atsushi ^a   Lurie, Keith G ^b   Efange, Simon M N ^c   Takahara, Akira ^a   Takehana, Shunji ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

AV node; Conduction; Coronary blood flow; m (Iodobenzyl)trozamicol (MIBT); Vesamicol

Indexed keywords

ACETYLCHOLINE; ATROPINE; DRUG VEHICLE; ION CHANNEL; META (IODOBENZYL)TROZAMICOL; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VESAMICOL; VESAMICOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR CONDUCTION; AUTONOMIC NEUROPATHY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG HALF LIFE; DRUG INHIBITION; FEMALE; HEART ATRIOVENTRICULAR NODE; MALE; NONHUMAN; PARASYMPATHETIC INNERVATION; VASODILATATION;

EID: 0034099290     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.82.150     Document Type: Article

References (10)

1. Marshall IG and Parsons SM: The vesicular acetylcholine transport system. Trends Neurol Sci 10, 174-177 (1987)
2. 125I]MIBT): Potential radioligand for mapping central cholinergic innervation. J Med Chem 36, 1754-1760 (1993)
3. 125I]MIBT in primate brain. Eur J Pharmacol 338, 159-169 (1997)
4. Coffeen PR, Efange SMN, Haidet GC, McKnite S, Langason RB, Khare AB, Pennington J and Lurie KG: Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand. Nucl Med Biol 23, 923-926 (1996)
5. Sugiyama A, Motomura S, Tamura K and Hashimoto K: Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 53, 97-110 (1990)
6. Sugiyama A, Motomura S and Hashimoto K: Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244, with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 56, 1-12 (1991)
7. Sugiyama A, Xue YX, Hagihara A, Saitoh M and Hashimoto K: Characterization of magnesium sulfate as an antiarrhythmic agent. J Cardiovasc Pharmacol Ther 1, 243-254 (1996)
8. Motomura S and Hashimoto K: Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine. Jpn J Pharmacol 52, 319-330 (1990)
9. Sugiyama A, Kobayashi M, Tsujimoto G, Motomura S and Hashimoto K: The first demonstration of CGRP-immunoreactive fibers in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated blood-perfused heart preparations. Jpn J Pharmacol 50, 421-427 (1989)
10. Sugiyama A, Motomura S and Hashimoto K: Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs. Jpn J Pharmacol 66, 303-316 (1994)